Qing-Yu He Selected Research

human MIRN335 microRNA

12/2021

Hsa-miR-335 enhances cell migration and invasion in lung adenocarcinoma through targeting Copine-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qing-Yu He Research Topics

Disease

66	Neoplasms (Cancer) 01/2022 - 01/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2004
16	Carcinogenesis 09/2021 - 01/2003
13	Infections 06/2022 - 02/2008
10	Esophageal Squamous Cell Carcinoma 01/2022 - 08/2008
10	Lung Neoplasms (Lung Cancer) 09/2021 - 02/2011
9	Esophageal Neoplasms (Esophageal Cancer) 11/2020 - 08/2008
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2016
8	Mitochondrial Diseases (Mitochondrial Disease) 09/2021 - 12/2007
8	Carcinoma (Carcinomatosis) 07/2017 - 01/2004
7	Hepatocellular Carcinoma (Hepatoma) 07/2017 - 05/2005
5	Bacterial Infections (Bacterial Infection) 01/2022 - 04/2008
5	Inflammation (Inflammations) 01/2022 - 05/2003
4	Adenocarcinoma of Lung 12/2021 - 02/2011
4	Leukemia 07/2014 - 04/2006
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 07/2009
3	Stomach Neoplasms (Stomach Cancer) 08/2012 - 01/2011
2	Wounds and Injuries (Trauma) 01/2022 - 01/2021
2	Adenocarcinoma 01/2014 - 07/2009
2	Nasopharyngeal Carcinoma 11/2013 - 07/2008
2	Breast Neoplasms (Breast Cancer) 03/2011 - 01/2007
2	Multiple Myeloma 09/2010 - 06/2009
2	Hypoxia (Hypoxemia) 01/2009 - 06/2008
2	Ischemia 06/2008 - 08/2007
1	Persistent Infection 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2021
1	Autoimmune Diseases (Autoimmune Disease) 06/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

42	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2003
19	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2003
14	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
7	Biological ProductsIBA 01/2022 - 10/2017
7	ProteomeIBA 12/2017 - 10/2011
6	IronIBA 06/2022 - 04/2008
5	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2011
4	PhosphoproteinsIBA 01/2021 - 03/2010
4	Messenger RNA (mRNA)IBA 07/2017 - 03/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
3	Peptides (Polypeptides)IBA 07/2021 - 05/2005
3	dioscinIBA 07/2014 - 04/2006
3	GenisteinIBA 08/2012 - 03/2010
3	ArsenicIBA 06/2009 - 01/2003
2	ElementsIBA 06/2022 - 08/2006
2	MetalsIBA 01/2022 - 01/2018
2	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022 - 10/2017
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022 - 08/2020
2	OligonucleotidesIBA 11/2020 - 01/2019
2	Oxidoreductases (Dehydrogenase)IBA 11/2020 - 07/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020 - 10/2017
2	CateninsIBA 10/2020 - 01/2018
2	Guanosine Triphosphate (GTP)IBA 01/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2010
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2018
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2018
2	matrigelIBA 01/2018 - 06/2017
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2007
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2004
2	ProhibitinsIBA 01/2018 - 07/2005
2	isodeoxyelephantopinIBA 01/2017 - 11/2013
2	UbiquitinIBA 12/2016 - 03/2016
2	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 11/2016 - 01/2013
2	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2016 - 09/2010
2	Transcription Factors (Transcription Factor)IBA 02/2016 - 01/2013
2	SaponinsIBA 07/2014 - 12/2007
2	GlucosidesIBA 07/2014 - 12/2007
2	Protein Kinases (Protein Kinase)IBA 09/2011 - 03/2010
2	gold (III) porphyrin 1aIBA 03/2008 - 01/2006
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2007 - 08/2006
2	TropomyosinIBA 07/2005 - 01/2004
1	CrizotinibIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	MethyltransferasesIBA 01/2022
1	Sirtuin 1IBA 01/2022
1	Anti-HIV Agents (AIDS Drugs)IBA 01/2022
1	inauzhinIBA 01/2022
1	IridiumIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Anti-Infective Agents (Microbicides)IBA 01/2022
1	elvitegravirIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	human MIRN335 microRNAIBA 12/2021
1	BMS201038IBA 09/2021
1	Beclin-1IBA 09/2021
1	Cyclin-Dependent Kinase 5IBA 07/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2021
1	NLR ProteinsIBA 06/2021
1	InflammasomesIBA 06/2021
1	IonomycinIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	azelastine (Optivar)FDA LinkGeneric 01/2021
1	CollagenIBA 01/2021

Therapy/Procedure

14	Therapeutics 09/2021 - 06/2009
2	Radiotherapy 10/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 10/2020 - 01/2017
2	Precision Medicine 10/2020 - 01/2020
1	Immunotherapy 01/2021